Live symposium, including Q&A sessions
on Thursday 12 May 2022, 17:00–18:30 CEST
Online and in-person at The Westin, Paris, France, 12–15 May 2022
Join our expert faculty to discuss the bigger picture with current real-world evidence for MM treatment decision-making, and discuss the new normal following the COVID-19 pandemic. The faculty will also delve into upcoming therapies that could pave the way for the future of MM treatment.
Each topic will be covered in a short presentation followed by a panel discussion and Q&A session with the following experts in MM:
Investigational medicines will be discussed at this meeting.
This meeting has been organised and sponsored by Takeda Oncology.
All trademarks are the property of their respective owners.
©2022 Takeda Pharmaceuticals International AG. All rights reserved.
VV-MEDMAT-66524 Date of prep: April 2022